On Wednesday, Verastem Inc (NASDAQ:VSTM)’s shares inclined 2.29% to $1.79.
Verastem, Inc. (VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, declared that the Company has stopped enrollment in the Phase 2 registration-directed, double-blind, placebo-controlled study (COMMAND) of VS-6063 for patients with mesothelioma. The decision to stop enrollment for futility followed a Data Safety Monitoring Board (DSMB) review of a pre-planned interim analysis. The results of the analysis demonstrated that VS-6063 had a generally well tolerated safety profile but that there was not a sufficient level of efficacy to warrant continuation of the study.
Verastem, Inc., a biopharmaceutical company, focuses on discovering and developing proprietary small molecule drugs targeting cancer stem cells (CSCs). The company’s programs target the focal adhesion kinase (FAK) and the PI3K/mTOR signaling pathways. Its lead FAK inhibitor, VS-6063, is in a registration-directed trial in patients with malignant pleural mesothelioma; a Phase Ib trial in combination with weekly paclitaxel for patients with ovarian cancer; a Phase II study in patients with non-small cell lung cancer; and a Phase II trial preceding surgery in mesothelioma, in addition to a combination trial of VS-6063 and VS-5584 in patients with relapsed mesothelioma.
Quantum Corp (NYSE:QTM)’s shares dropped -0.34% to $0.697.
Quantum Corp. (QTM) declared the appointment of Bassam Tabbara as chief technology officer, with responsibility for driving the company’s long-term technology strategy as it builds on its leadership in scale-out storage, archive and data protection. Tabbara has more than 20 years of experience in planned product development — identifying and delivering on new innovation opportunities. He joined Quantum in August 2014 as part of its acquisition of Symform’s cloud platform, having served as the company’s CTO and co-founder.
Since joining Quantum, Tabbara has played a key role in defining the company’s cloud technology direction and in the development of its new Q-Cloud™ service offerings. These offerings enable customers to integrate the public cloud seamlessly into a multitier storage architecture that provides a unique combination of high performance and low cost.
At Symform, Tabbara built a revolutionary cloud storage platform from the ground up, ultimately storing billions of objects for users and small businesses across 170 countries. Before that, he spent 12 years at Microsoft in key leadership roles where he worked on a number of key initiatives, counting Microsoft Research, MSN, Windows, Visual Studio and System Center. Tabbara also holds more than 30 patents.
Quantum Corporation provides scale-out storage, archive, and data protection solutions for small businesses to major enterprises in the Americas, Europe, and the Asia Pacific. Its scale-out storage portfolio comprises StorNext software, appliances and full systems called StorNext Pro Solutions, in addition to Lattus extended online storage and Q-Cloud Archive services.
At the end of Wednesday’s trade, Humana Inc (NYSE:HUM)‘s shares surged 1.84% to $179.00.
Humana Inc. (HUM) declared that it now offers talking prescription labels, at no cost, to blind and visually impaired members who fill prescriptions through Humana Pharmacy, Inc. and at its seven PrescribeIT Rx locations in Florida. Humana, a leading health and well-being company, worked on its accessible prescription initiative with the American Council of the Blind and individual blind members in Nevada, Florida and Georgia.
Humana offers talking labels offered by the ScripAbility prescription accessibility system, a service of En-Vision America. The talking labels provide people who cannot read standard print a safe and convenient way to access information on prescription labels. Humana members who are blind, have low vision, or those who have dyslexia will particularly benefit from the new service. Braille labels are also accessible through the Humana mail-order Pharmacy.
Humana Inc., together with its auxiliaries, operates as a health and well-being company. The company operates through three segments: Retail, Group, and Healthcare Services. The Retail segment provides Medicare and commercial fully-insured medical and specialty health insurance benefits, counting dental, vision, and other supplemental health and financial protection products directly to individuals.
CNH Industrial NV (NYSE:CNHI), ended its Wednesday’s trading session with 2.19% gain, and closed at $6.52.
CNH Industrial N.V. (CNHI) agricultural machinery brand New Holland Agriculture, industry leader in grape and olive harvesting and specialist tractors, has come out on top for the SITEVI Innovation Awards. The jury declared its winners ahead of SITEVI 2015, the international equipment and expertise exhibition for wine, olive, fruit and vegetable production, which will take place later this year from 24 – 26 November in Montpellier, France.
New Holland’s self-propelled grape harvesters received the recognition of the jury, who awarded a gold medal for the Blue Cab 4 and an honourable mention was awarded to the PLM™ Connect telematics system accessible on grape harvesters and the T4F/N/V orchard, narrow and vineyard tractor range.
The Blue Cab 4 is an innovative cab concept designed around the safety and well-being of the operator. It features the industry’s most advanced filtration system. PLM™ Connect is a telematics solution that enables vineyard managers to be well connected with their operation, allowing them to stay in direct contact with their fleet, receiving real time data on their computer or smartphone. The application of telematics is of increasing value as the wine growing sector consolidates, with fewer vineyard businesses working larger areas, and with the harvesting season getting shorter, the need for efficiency has significantly raised.
CNH Industrial N.V. designs, produces, markets, sells, and finances agricultural and construction equipment, trucks, commercial vehicles, buses, and specialty vehicles, engines, transmissions, and axles worldwide.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
